Parametric Portfolio Associates’s Thorne Healthtech, Inc. Common Stock THRN Stock Holding History

Parametric Portfolio Associates’s Portfolio THRN Stock Details THRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$288K	Buy	+45,355	New	+$244K	﹤0.01%	3300

Other funds holding THRN

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Emerald Advisers Leola, Pennsylvania $4.25B AUM 141.71% 1-Year Est. Return

EMFAT

Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.85B AUM 140.52% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Scout Investments Kansas City, Missouri $3.8B AUM 45.91% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

MYDA Advisors Woodmere, New York $672M AUM 71.14% 1-Year Est. Return

Parametric Portfolio Associates's THRN Position: Q1 2022 in Review

Parametric Portfolio Associates opened a new position in Thorne Healthtech, Inc. Common Stock (THRN) in Q1 2022: 45,355 shares worth $288K. The stake represents ﹤0.01% of the portfolio and ranks #3300 among its holdings.

48 funds tracked by Wall St. Rank hold THRN as of Q1 2022.

Parametric Portfolio Associates held 45,355 shares of Thorne Healthtech, Inc. Common Stock worth $288K as of Q1 2022.
Thorne Healthtech, Inc. Common Stock was a new Parametric Portfolio Associates position in Q1 2022.
Thorne Healthtech, Inc. Common Stock made up ﹤0.01% of Parametric Portfolio Associates's portfolio in Q1 2022, its #3300 holding.
48 funds tracked by Wall St. Rank held Thorne Healthtech, Inc. Common Stock as of Q1 2022.

Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.